Metreleptin

ATC A16AA07 · 5 markets · 11 records

Metreleptin 5 markets · 11 records Forms

GB 3 records · 3 strengths

11.3 mginjectionMyalepta 3mg powder for solution for injection vials also in ES
5.8 mginjectionMyalepta 3mg powder for solution for injection vials also in ES
3 mginjectionMyalepta 3mg powder for solution for injection vials also in ES

CA 3 records · 3 strengths

11.3 mgpowderMYALEPTA
5.8 mgpowderMYALEPTA
3 mgpowderMYALEPTA

ES 3 records · 3 strengths

11.3 mginjectionMYALEPTA also in GB
5.8 mginjectionMYALEPTA also in GB
3 mginjectionMYALEPTA also in GB

US 1 records · 1 strengths

11.3 mg/2.2 mLinjectionMyalept

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 MYALEPTA

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.